Milbemycin oxime 129496-10-2 Anti-Parasitics Antibiotic
Payment: T/T, L/C
Product Origin: China
Shipping Port: Beijing/Shanghai/Hangzhou
Order (MOQ): 1kg
Lead Time: 3 working days
Production capacity: 30kg/month
Storage condition: Stored in cool, dry place, room temperature.
Package material: bottle
Package size: 1kg/bottle
Safety information: Not dangerous goods
Introduction
It is a macrolide antibody internal and external parasite drug, and is an oxime derivative of milbemycin A3 and A4.
Milbemycin oxime, is a veterinary medication from the group of milbemycins, used as a broad spectrum antiparasitic. It is active against worms (anthelmintic) and mites (miticide).
Specification (USP42)
Item |
Specification |
Appearance | White or off-white powder |
Identification | Infrared spectroscopy |
The retention times of the major peaks of the Sample solution correspond to those of the Standard solution, as obtained in the Assay. | |
Residue on ignition | ≤0.5% |
Organic impurities | 11’-Desmethylmibemycin A4 oxime ≤0.7% |
(20’R)-Hydroxymilbemycin A4 keto form ≤0.5% | |
Milbemycin A4 keto form ≤0.7% | |
Milbemycin D-oxime ≤3.0% | |
Any other individual impurity ≤0.5% | |
Total impurities ≤3.5% | |
Water determination | ≤3.0% |
Residual solvents | Ethanol ≤5000ppm |
N-Heptane ≤5000ppm | |
Acetone ≤5000ppm | |
Dichloromethane ≤600ppm | |
Chloroform ≤60ppm | |
Microbial limit | Total aerobic bacteria ≤500cfu/g |
Total combined yeasts and molds ≤100cfu/g | |
Escherichia coli Absent/g | |
Assay | Milbemycin Oxime (A3+A4): 95.0%~101.0%, calculated on the anhydrous basis |
Ratio A4 / (A3+A4) ≥0.80 | |
Ratio A3 / (A3+A4) ≤0.20% |